Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Cel-Sci expands Multikine trial

Dec. 12, 1997

New data on PDL's SMART M195 antibody reported

Dec. 12, 1997

FDA approves Neoprobe's IND for RIGS/ACT therapy

Dec. 11, 1997

ImmunoGen's C242-DM1 found safe in preclinical studies

Dec. 10, 1997

ImClone and Merck KGaA expand collaboration for BEC2 cancer vaccine

Dec. 10, 1997

Ono-4007: antitumor lipid A analogue that enhances TNF production by macrophages

Dec. 10, 1997

StressGen prepares to evaluate Oncocine in clinical trials

Dec. 9, 1997

Seragen submits BLA for CTCL biological product

Dec. 9, 1997

IL-12 for treatment of malignant tumors

Dec. 8, 1997

OncoVax-P clinical data reported at scientific meeting

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...